Ophthotech gains commericial rights to AMD antibody

Article

Ophthotech, Biogen and PDL BioPharma have entered into an exclusive worldwide licensing agreement for an anti-angiogenesis antibody to treat age-related macular degeneration.

Ophthotech, Biogen and PDL BioPharma have entered into an exclusive worldwide licensing agreement for an anti-angiogenesis antibody to treat age-related macular degeneration (AMD).

Under the terms of the agreement, Biogen and PDL have granted Ophthotech worldwide development and commercial rights to all ophthalmic uses of volociximab, an investigational monoclonal antibody targeting (alpha)5(beta)1 integrin, a key protein involved in the formation of blood vessels.

Biogen and PDL will each receive an equity position in Ophthotech as well as a combination of development milestone payments and royalties on future product sales.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Subscribe Now!
Recent Videos
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Related Content
A woman with glasses helps a child, who may be her daughter, use a tablet. Concept image for online school, homeschool, screen time, myopia, and paediatric astigmatism. Image credit: ©K2L Family – stock.adobe.com

Research links COVID-19 to prevalence and severity of paediatric astigmatism

Lynda Charters
May 20th 2025
Article

The study found an increase in both refractive astigmatism and corneal astigmatism among a patient population of schoolchildren

PHOTON Results and Their Relation to DME Patients in Your Practice

PHOTON Results and Their Relation to DME Patients in Your Practice

July 25th 2024
Podcast

John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.

A group of elderly women navigate a street in Europe. Concept image for age-related macular degeneration and geographic atrophy. Image credit: ©Zelma – stock.adobe.com

How patients navigate quality-of-life challenges associated with geographic atrophy

Lynda Charters
May 15th 2025
Article

Investigators sought to understand the diagnostic path, symptoms, quality of life impact and coping mechanisms of patients with GA in western Europe and the United States

PULSAR Results and Their Relation to nAMD Patients in Your Practice

PULSAR Results and Their Relation to nAMD Patients in Your Practice

July 24th 2024
Podcast

John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.

A woman holds an ice cube near her face. Concept image for chronic ocular surface pain treatment, EyeCool Therapeutics corneal cooling technology for dry eye disease. Image credit: ©dream@do – stock.adobe.com

EyeCool Therapeutics announces results from pilot study of novel chronic ocular surface pain treatment

Hattie Hayes
May 12th 2025
Article

The investigational device, ETX-4143, was the focus of a study involving 31 patients with COSP in Australia

A series of kidney scans. Concept image for retinal biomarker scan, kidney function, lupus and autoimmune disease. Image credit: ©Sved Oliver – stock.adobe.com

Retinal microvascular changes in patients with systemic lupus erythematosus: Importance of OCTA

Lynda Charters
May 12th 2025
Article

The biomarkers are especially crucial for patients with lupus nephritis

© 2025 MJH Life Sciences

All rights reserved.